Heather Kurz
Nurse Practitioner · Pleasant Hill, CANPI 1619515830
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,380 of the $4,007 with a category attached, or 84.3%. It is spread thinly across 35 manufacturers, the largest accounting for just 15.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $3,302 and has fallen 99.1% since, to $29 in 2025. Among nurse practitioner clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 146 payments — averaging $27.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$606
- Seagen Inc.$395
- Takeda Pharmaceuticals U.S.A., Inc.$348
- Daiichi Sankyo Inc.$301
- AstraZeneca$296
- Incyte Corporation$270
- plus $2K from 29 others
What the payments were for
- Food & beverage$3,38084%
- Education$62816%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 17 | $606 |
| Seagen Inc. | 15 | $395 |
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $348 |
| Daiichi Sankyo Inc. | 9 | $301 |
| AstraZeneca(2 entities) | 9 | $296 |
| Incyte Corporation | 4 | $270 |
| Merck | 10 | $192 |
| Astellas Pharma US Inc | 6 | $184 |
| Lilly USA, LLC | 3 | $139 |
| AbbVie | 1 | $125 |
| ADC Therapeutics America, Inc. | 1 | $122 |
| Novartis | 5 | $109 |
| Pharmacyclics LLC, An Abbvie Company | 5 | $102 |
| Myovant Sciences Inc. | 4 | $101 |
| GSK | 4 | $88 |
| Johnson & Johnson(2 entities) | 4 | $72 |
| Pfizer | 4 | $67 |
| Karyopharm Therapeutics Inc. | 2 | $60 |
| Bristol Myers Squibb | 2 | $46 |
| Bayer | 2 | $44 |
| Eisai Inc. | 2 | $40 |
| E.r. Squibb & Sons, L.L.C. | 2 | $37 |
| Blueprint Medicines Corporation | 2 | $33 |
| Heron Therapeutics, Inc. | 2 | $32 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
| Ipsen Biopharmaceuticals, Inc | 1 | $26 |
| Acrotech Biopharma Inc. | 1 | $26 |
| Beigene USA, Inc. | 1 | $19 |
| Sanofi | 1 | $19 |
| Gilead | 1 | $18 |
| Boehringer Ingelheim | 1 | $16 |
| Mayne Pharma Commercial LLC | 1 | $16 |
| EMD Serono, Inc. | 1 | $16 |
| Array Biopharma Inc | 1 | $12 |
| Genentech USA, Inc. | 1 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,007 in reported general payments places this provider in the 90th percentile of 6,779 nurse practitioner providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Exemestane | 104 | $8,424 |
| Anastrozole | 92 | $2,593 |
| Letrozole | 111 | $2,261 |
| Tamoxifen Citrate | 15 | $330 |
| Alendronate Sodium | 17 | $167 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Pleasant Hill
- Rhonda HewittStanford$917K
- Linda TrinhIrvine$884K
- Denise SinagaNorthridge$728K
- Debbie TaySanta Monica$642K
- Joe GorelickCampbell$638K
- Lynsey LakinArcadia$540K
- Kelly ChoiRancho Cucamonga$483K
- Hamta ZareStanford$428K
- Shawna ChrismanRoseville$425K
- Angelina CollinsSan Diego$356K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.